ALPS ETF TR - MED BREAKTHGH (SBIO)

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / MED BREAKTHGH
Total 13F shares
1,406,121
Share change
-12,183
Total reported value
$44,270,591
Put/Call ratio
4.3%
Price per share
$31.55
Number of holders
40
Value change
-$128,381
Number of buys
15
Number of sells
15

Institutional Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q2 2023

As of 30 Jun 2023, ALPS ETF TR - MED BREAKTHGH (SBIO) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,406,121 shares. The largest 10 holders included DAVENPORT & Co LLC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, UBS Group AG, Raymond James Financial Services Advisors, Inc., Strategic Financial Services, Inc,, NTV Asset Management LLC, WELLS FARGO & COMPANY/MN, Royal Bank of Canada, and LPL Financial LLC. This page lists 40 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.